Hi, what is your YTD revenue compared to 2023 YTD? Can you share more in terms of your recent traction? This looks like a very compelling opportunity but the valuation seems to require some market adoption. Thanks

Hello, Yosef! Thank you for the inquiry and you are spot on. Market adoption is the name of the game once all regulatory hurdles are cleared, and workflow engineering completed. Emerging from Covid hospitals, health systems and physician practices were not in a position to invest into many new emerging technologies, so we are just now seeing signs of ability and willingness to invest. 2023 YTD vs. 2024 YTD revenue is up 142%. Our leading indicator for traction is a) customer pilots coming onl...

Hi, Can you please describe how you differentiate from other companies (i.e. Rad AI--that recently just closed a $50 Series B round). Are they a direct competitor? Thanks!

Jorinda, Thank you for the interest in Koios and your great question. There are other excellent companies already making a positive impact in Radiology and it can be a challenge distinguishing among them. Rad AI for example is a great software that automatically creates an "impression" from a radiologist's dictated findings. In other words, they help create a consistent, final report from the highly variable ways in which physicians and interpret/document and/or dictate findings into their re...

Hello Chad, You are on to a great disruption and I love the progress you and your team made thus far. I am an angel investor, would love to get on a call with you to clarify few things before I commit.

Prakash, Thank you for your interest and kind/encouraging words. It would be our pleasure to connect on a call to share our story further and hopefully answer any questions you may have. Please send me an email with your availability for a call. cmcclennan@koiosmedical.com Regards, Chad

Can you share your thoughts on how often you will update us on how things are progressing with your goals and business plan? Secondly, do you intend to file the annual report with the SEC? Thanks for your feedback.

Eric, Thank you for asking and for your interest in Koios Medical. Historically we have provided regular progress reports to investors both in the form of bi-annual detailed reports combined with ad-hoc announcements related to key milestones such as regulatory approvals and strategic relationships (FDA clearance, CE Marks, worldwide distribution agreement with GE and others). Now that we are growing our wonderful Koios Community here through WeFunder, I would like to ask how often would our ...

Hi Chad, I would like to invest in your company, but you've set the minimum investment TOO high! Perhaps you might consider the limitations placed on Non-accredited investors (read 'small investors') by the SEC . If I make less than $107K/year I cannot by law invest more than ...

Kim, Thank you for your interest and for your suggestion and compelling, detailed rationale provided. We definitely understand your point and will certainly take it into consideration. There are both pros and cons to offering a lower minimum, but I commit to discussing internally and take your input under advisement. Thank you again. Best regards, Chad

Invest in Koios Medical, Inc.

FDA-cleared AI MedTech detecting more cancer early. Featured by NBC, NPR and WSJ.

$1,577,206

of a $2,000,000 goal

INVEST

min $500

INVESTMENT TERMS

Preferred Stock

$90M pre-money valuation $4.70 per share

$1K, $10K, $25K, $50K, $100K, $250K

koiosmedical.com

New York, NY

Technology B2B Healthcare SaaS Hardware

Ask a Question

Koios Medical, Inc.

Quick facts

Investor memo sources

Team profiles

Featured investor profiles

$1,577,206

Ask